Affordable Access

deepdyve-link
Publisher Website

Plumbagin modulates leukemia cell redox status.

Authors
  • Gaascht, François1
  • Teiten, Marie-Hélène2
  • Cerella, Claudia3
  • Dicato, Mario4
  • Bagrel, Denyse5
  • Diederich, Marc6
  • 1 Laboratoire de Biologie Moléculaire et Cellulaire du Cancer (LBMCC), Hôpital Kirchberg, 9, Rue Edward Steichen, L-2540 Luxembourg, Grand-Duchy of Luxembourg. [email protected] , (Luxembourg)
  • 2 Laboratoire de Biologie Moléculaire et Cellulaire du Cancer (LBMCC), Hôpital Kirchberg, 9, Rue Edward Steichen, L-2540 Luxembourg, Grand-Duchy of Luxembourg. [email protected] , (Luxembourg)
  • 3 Laboratoire de Biologie Moléculaire et Cellulaire du Cancer (LBMCC), Hôpital Kirchberg, 9, Rue Edward Steichen, L-2540 Luxembourg, Grand-Duchy of Luxembourg. [email protected] , (Luxembourg)
  • 4 Laboratoire de Biologie Moléculaire et Cellulaire du Cancer (LBMCC), Hôpital Kirchberg, 9, Rue Edward Steichen, L-2540 Luxembourg, Grand-Duchy of Luxembourg. [email protected] , (Luxembourg)
  • 5 Laboratoire Structure et Réactivité des Systèmes Moléculaires Complexes, UMR CNRS 7565, Université de Lorraine, Campus Bridoux, Rue du Général Delestraint, F-57070 Metz, France. [email protected] , (France)
  • 6 Department of Pharmacy, College of Pharmacy, Seoul National University, Seoul 151-742, Korea. [email protected] , (North Korea)
Type
Published Article
Journal
Molecules
Publisher
MDPI AG
Publication Date
Jul 10, 2014
Volume
19
Issue
7
Pages
10011–10032
Identifiers
DOI: 10.3390/molecules190710011
PMID: 25014531
Source
Medline
Language
English
License
Unknown

Abstract

Plumbagin is a plant naphtoquinone exerting anti-cancer properties including apoptotic cell death induction and generation of reactive oxygen species (ROS). The aim of this study was to elucidate parameters explaining the differential leukemia cell sensitivity towards this compound. Among several leukemia cell lines, U937 monocytic leukemia cells appeared more sensitive to plumbagin treatment in terms of cytotoxicity and level of apoptotic cell death compared to more resistant Raji Burkitt lymphoma cells. Moreover, U937 cells exhibited a ten-fold higher ROS production compared to Raji. Neither differential incorporation, nor efflux of plumbagin was detected. Pre-treatment with thiol-containing antioxidants prevented ROS production and subsequent induction of cell death by apoptosis whereas non-thiol-containing antioxidants remained ineffective in both cellular models. We conclude that the anticancer potential of plumbagin is driven by pro-oxidant activities related to the cellular thiolstat.

Report this publication

Statistics

Seen <100 times